Heartbeam Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as specified in its charter)
|
(State or other jurisdiction |
(Commission File Number) |
(IRS Employer |
(Address of principal executive offices, including zip code)
(
(Registrant’s telephone number, including area code)
Check the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 Submission of Matters to a Vote of Security Holders
On June 12, 2024, HeartBeam, Inc. (the “Company”) held an annual meeting of stockholders (the “Annual Meeting”) virtually, via live webcast.
As of the close of business on April 15, 2024, the record date for the Annual Meeting (the “Record Date”), 26,329,032 shares of the Company’s common stock, par value $0.0001 (the “Common Stock”) were outstanding and entitled to vote. At the Annual Meeting, a total of 15,510,613 votes, comprised of shares of the Company’s Common Stock, equivalent to approximately 58.91% of the outstanding votes, were represented in person or by proxy at the Annual Meeting, constituting a quorum. The matters that were voted upon at the Annual Meeting, and the number of votes cast for or against/withheld, as well as the number of abstentions and broker non-votes, as to such matters, where applicable, are set forth below.
1. The eight nominees for director were elected to serve a one-year term as follows:
| Director | Votes For | Votes Against | Abstain | Broker Non-Vote | ||||||||||||
| Richard Ferrari | 7,320,527 | 1,208,286 | 39,325 | 6,942,475 | ||||||||||||
| Branislav Vajdic, PhD | 8,521,425 | 35,607 | 11,106 | 6,942,475 | ||||||||||||
| George A. de Urioste | 7,202,993 | 1,241,931 | 123,214 | 6,942,475 | ||||||||||||
| Marga Ortigas-Wedekind | 8,118,897 | 409,905 | 39,336 | 6,942,475 | ||||||||||||
| Willem Elfrink | 7,700,810 | 821,010 | 46,318 | 6,942,475 | ||||||||||||
| Mark Strome | 7,768,881 | 781,158 | 18,099 | 6,942,475 | ||||||||||||
| Kenneth Nelson | 8,281,294 | 268,806 | 18,038 | 6,942,475 | ||||||||||||
| Michael Jaff | 8,517,942 | 3,868 | 46,328 | 6,942,475 | ||||||||||||
2. The proposal to ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 was approved as follows:
| Votes For | Votes Against | Broker Non-Votes | Votes Abstained | ||||
| 15,480,741 | 5,967 | 0 | 23,905 |
3. The proposal to amend the 2022 Equity Incentive Plan to increase the number of authorized shares from 5,900,000 shares to 8,900,000 shares:
| Votes For | Votes Against | Broker Non-Votes | Votes Abstained | ||||
| 6,690,616 | 1,853,898 | 6,942,475 | 23,624 |
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
| Exhibit Number |
Description | |
| 10.1 | Second Amendment to the HeartBeam, Inc. 2022 Equity Incentive Plan | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| HeartBeam, Inc. | ||
| Date: June 17, 2024 | /s/ Branislav Vajdic | |
| Name: | Branislav Vajdic | |
| Title: | Chief Executive Officer | |
2